NIPSCO agreed to reduce its revenue request by 30% in the latest rate hike it's seeking after reaching a settlement with large business customers.

Rockville’s MaxCyte has made its first acquisition in its more than quarter-century of operation. It’s keeping its eyes out ...

ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth ...

Some think investing in stocks requires substantial start-up capital, but that's false. Even with a modest sum, like $40, ...

SAN CARLOS, Calif. - Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company focused on novel cancer treatments, announced today the appointment of Dan Kirby (NYSE:KEX) as Chief ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

The SCIg market is growing rapidly, with KORU Medical Systems outperforming competitors by capturing market share. Read why I ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

In Netflix's 'Apple Cider Vinegar,' Milla Blake tries to heal her sarcoma holistically. Her story is similar to that of ...

Learn more about whether Enovis Corporation or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The FDA last month accepted the application for subcutaneous Leqembi for maintenance dosing, with a target action date of ...